Zhiying Yue

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

PARG inhibition in ATM-deficient prostate cancer: from mechanistic discovery to therapeutic potential.

PARG inhibition in ATM-deficient prostate cancer: from mechanistic discovery to therapeutic potential.

Journal: Journal of translational medicine

Published: December 15, 2025

Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer.

Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer.

Journal: Cancer research

Published: June 18, 2025

NDUFS1 upregulates ENaCα by NAD+ to promote alveolar fluid clearance in acute lung injury.

NDUFS1 upregulates ENaCα by NAD+ to promote alveolar fluid clearance in acute lung injury.

Journal: International journal of medical sciences

Published: February 15, 2025

Cathepsin K Aggravates Pulmonary Fibrosis Through Promoting Fibroblast Glutamine Metabolism and Collagen Synthesis.

Cathepsin K Aggravates Pulmonary Fibrosis Through Promoting Fibroblast Glutamine Metabolism and Collagen Synthesis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 15, 2024

Research progress of dihydromyricetin in the treatment of diabetes mellitus.

Research progress of dihydromyricetin in the treatment of diabetes mellitus.

Journal: Frontiers in endocrinology

Published: May 10, 2023

AMPK activation coupling SENP1-Sirt3 axis protects against acute kidney injury.

AMPK activation coupling SENP1-Sirt3 axis protects against acute kidney injury.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: February 02, 2023

A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling.

A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling.

Journal: Molecular cell

Published: October 11, 2022

RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis.

RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis.

Journal: The Journal of clinical investigation

Published: September 23, 2020

HOXD13 suppresses prostate cancer metastasis and BMP4-induced epithelial-mesenchymal transition by inhibiting SMAD1.

HOXD13 suppresses prostate cancer metastasis and BMP4-induced epithelial-mesenchymal transition by inhibiting SMAD1.

Journal: International journal of cancer

Published: July 22, 2020

Calcium Homeostasis: A Potential Vicious Cycle of Bone Metastasis in Breast Cancers.

Calcium Homeostasis: A Potential Vicious Cycle of Bone Metastasis in Breast Cancers.

Journal: Frontiers in oncology

Published: November 26, 2019

SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis.

SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis.

Journal: Nature communications

Published: October 05, 2019

Regulation of body length and bone mass by Gpr126/Adgrg6.

Regulation of body length and bone mass by Gpr126/Adgrg6.

Journal: Science advances

Published: August 08, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026